DEM BioPharma Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$70M
- Investors
-
9
DEM BioPharma General Information
Description
Developer of an immunotherapeutics platform designed to pioneer the next generation of macrophage immunotherapies. The company's platform researches the generation of immunotherapeutics that unleash macrophages and immune phagocytes to eliminate tumors by targeting signals on cancer cells and macrophages, enabling healthcare researchers with a treatment that removes cancer.
Contact Information
Website
www.dembiopharma.comCorporate Office
- 730 Main Street
- 5th Floor
- Cambridge, MA 02139
- United States
Corporate Office
- 730 Main Street
- 5th Floor
- Cambridge, MA 02139
- United States
DEM BioPharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 23-Jun-2022 | $70M | Completed | Generating Revenue | ||
| 1. Seed Round | Completed | Startup |
DEM BioPharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
DEM BioPharma Comparisons
Industry
Financing
Details
DEM BioPharma Competitors (91)
One of DEM BioPharma’s 91 competitors is Zelluna, a Formerly VC-backed company based in Oslo, Norway.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Zelluna | Formerly VC-backed | Oslo, Norway | ||||
| Eureka Therapeutics | Venture Capital-Backed | Emeryville, CA | ||||
| Navrogen | Venture Capital-Backed | Cheyney, PA | ||||
| Dendreon | Formerly VC-backed | Seal Beach, CA | ||||
| Carina Biotech | Venture Capital-Backed | Mawson Lakes, Australia |
DEM BioPharma Patents
DEM BioPharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026112624-A2 | Anti-smagp antibodies | Pending | 25-Nov-2024 | ||
| WO-2026112624-A3 | Anti-smagp antibodies | Pending | 25-Nov-2024 | ||
| WO-2025194014-A1 | Hetero aryl modulators of apmap and uses thereof | Pending | 15-Mar-2024 | ||
| WO-2025194015-A1 | Heteroaryl modulators of gpr84 and uses thereof | Pending | 15-Mar-2024 | ||
| WO-2024258897-A1 | Alkoxypyridinyl and related compounds and their use in therapy | Inactive | 13-Jun-2023 | C07D213/69 |
DEM BioPharma Signals
DEM BioPharma Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alexandria Venture Investments | Venture Capital | Minority | ||
| Alta Partners | Venture Capital | Minority | ||
| Astellas Venture Management | Corporate Venture Capital | Minority | ||
| DC Investment Partners | Venture Capital | Minority | ||
| Emerson Collective | Impact Investing | Minority |
DEM BioPharma FAQs
-
When was DEM BioPharma founded?
DEM BioPharma was founded in 2022.
-
Where is DEM BioPharma headquartered?
DEM BioPharma is headquartered in Cambridge, MA.
-
What is the size of DEM BioPharma?
DEM BioPharma has 20 total employees.
-
What industry is DEM BioPharma in?
DEM BioPharma’s primary industry is Drug Discovery.
-
Is DEM BioPharma a private or public company?
DEM BioPharma is a Private company.
-
What is the current valuation of DEM BioPharma?
The current valuation of DEM BioPharma is .
-
What is DEM BioPharma’s current revenue?
The current revenue for DEM BioPharma is .
-
How much funding has DEM BioPharma raised over time?
DEM BioPharma has raised $95M.
-
Who are DEM BioPharma’s investors?
Alexandria Venture Investments, Alta Partners, Astellas Venture Management, DC Investment Partners, and Emerson Collective are 5 of 9 investors who have invested in DEM BioPharma.
-
Who are DEM BioPharma’s competitors?
Zelluna, Eureka Therapeutics, Navrogen, Dendreon, and Carina Biotech are some of the 91 competitors of DEM BioPharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process